Properties
Description
Mofezolac blocks the COX enzymes from converting arachidonic acid to prostaglandins, thereby reducing inflammatory reactions.
Molecular Formula
C19H17NO5
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
Mofezolac can be used to explore its effectiveness as an anti-inflammatory agent through selective inhibition of cyclooxygenase-2 (COX-2).
